common.study.topics.clinical

Treatment for Methamphetamine-Use Disorder

common.study.values.description

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

This study will evaluate the behavioral effects of methamphetamine during maintenance on placebo, duloxetine, methylphenidate and duloxetine combined with methylphenidate using sophisticated human laboratory methods.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Methamphetamine

In each arm, subjects will receive doses of methamphetamine.

Drug - Methylphenidate

In each arm, subjects will receive methylphenidate capsules.

Drug - Placebo oral capsule

In each arm, subjects will receive placebo capsules.

Drug - Duloxetine

Subjects will receive duloxetine capsules in the duloxetine arm.

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Novel Drug Combination as a Pharmacotherapeutic for Methamphetamine-Use Disorder

common.study.values.clinical-trial-id

NCT04178993

participant.views.study.view.id

dNkzLe